TotalMarketCap

Arcus Biosciences

RCUSNYSE United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$2.554 B

$17.74 -8.13%

Close of 6 Nov 2026

As of 6 Nov 2026, Arcus Biosciences (RCUS) has a market capitalization of $2.55B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$247.0M

#2200 by revenue

Earnings

-$353.0M

Loss-making

Shares outstanding

143,990,614

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #77Vicore Pharma Holding ABVCRE$2.95B
  2. #78XencorXNCR$2.56B
  3. #79Arcus BiosciencesRCUS$2.55B
  4. #80Zai LabZLAB$2.54B
  5. #81HUTCHMED (China)HCM$2.48B

What if Arcus Biosciences were worth as much as…

Open the what-if tool →

Gold $28.2T

$196,102.18

Per share 11,054× higher

Bitcoin $1.53T

$10,610.75

Per share 598× higher

Apple $5.02T

$34,834.09

Per share 1,964× higher

Or at a round number

$5.00B$10.0B$20.0B$50.0B

Where these numbers come from

Share counts and financials for Arcus Biosciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.